In addition, previous clinical studies showed that in the OGTT, participants with impaired glucose tolerance are characterized by a significant increase in post-load glucose levels in the late phase (60 to 120 min) but not by a reduction of insulin secretion in the early phase (75, 83). This evidence concerns the gene INS and Impaired glucose tolerance.